Mujoo K, Choi BK, Huang Z, Zhang N, An Z. Regulation of ERBB3

[1] Mujoo K, Choi BK, Huang Z, Zhang N, An Z. Regulation of ERBB3/HER3 signaling in cancer. Oncotarget. 2014 Nov 15;5(21):10222-36.
[2] American Cancer Society. Breast Cancer Overview. 2016.
[3] Chiu CG, Masoudi H, Leung S, Voduc DK, Gilks B, Huntsman DG, Wiseman SM. HER-3 overexpression is prognostic of reduced breast cancer survival: a study of 4046 patients. Ann Surg. 2010 Jun;251(6):1107-16. doi: 10.1097/SLA.0b013e3181dbb77e.
[4] National Cancer Institute. Breast Cancer PDQ. 2016.
[5] De Melo Gagliato D, Jardim DL, Marchesi MS, Hortobagyi GN. Mechanisms of resistance and sensitivity to anti-HER2 therapies in HER2+ breast cancer. Oncotarget. 2016 Sep 27;7(39):64431-64446. doi: 10.18632/oncotarget.7043.